Hao Xu
- Cancer Research top 10%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 5
- Pharmacology top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
-
- Cancer Research and Treatments 8
-
- Pancreatic and Hepatic Oncology Research 8
- Cancer Cells and Metastasis 6
- Co-authors
- Mitchell GoldfarbJianchun CaiLinpei WangHuiqin ZhuoLingyun LinJia ChengJingjing HouWence Zhou
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (9 papers)Gastroenterology (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Hao Xu
108 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 248
- Molecular Biology 513
- Pathology and Forensic Medicine 112
- Hepatology 43
- Pharmacology 45
Countries citing papers authored by Hao Xu
This map shows the geographic impact of Hao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Xu more than expected).
Fields of papers citing papers by Hao Xu
This network shows the impact of papers produced by Hao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Xu. The network helps show where Hao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 24 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 1 | |
| 14 | The Immune-Related Gene ELF3 is a Novel Biomarker for the Prognosis of Ovarian Cancer | 2021 | 1 |
| 15 | circHIPK3 Promotes Cell Proliferation and Migration of Gastric Cancer by Sponging miR-107 and Regulating BDNF Expression | 2020 | 4 |
| 16 | RGD- and VEGF-Mimetic Peptide Epitope-Functionalized Self-Assembling Peptide Hydrogels Promote Dentin-Pulp Complex Regeneration | 2020 | 1 |
| 17 | Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells | 2019 | 1 |
| 18 | Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis | 2017 | 1 |
| 19 | Glioma-targeting micelles for optical/magnetic resonance dual-mode imaging | 2015 | 3 |
| 20 | The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles | 2013 | 2 |
About Hao Xu
Hao Xu is a scholar working on Microbiology, Cancer Research and Biotechnology, having authored 126 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Cancer Research and Treatments (8 papers), MicroRNA in disease regulation (8 papers), Pancreatic and Hepatic Oncology Research (8 papers), Circular RNAs in diseases (7 papers), Cancer Cells and Metastasis (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (248 citations), Molecular Biology (513 citations) and Pathology and Forensic Medicine (112 citations). Hao Xu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Mitchell Goldfarb, Jianchun Cai, Linpei Wang, Huiqin Zhuo, Lingyun Lin, Jia Cheng, Jingjing Hou, Wence Zhou, Yongjun Wang and Huan Tang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.